The Medicaid Cost of Palivizumab

por Ambrose, Christopher S., McLaurin, Kimmie K.
Publicado 2015

Modeling the Potential Impact of the 2014 American Academy of Pediatrics Respiratory Syncytial Virus Prophylaxis Guidance on Preterm Infant RSV Outcomes

por McLaurin, Kimmie K., Chatterjee, Archana, Makari, Doris
Publicado 2015

Hospitalizations in the First Year of Life for Infants with Respiratory Syncytial Virus and Unspecified Bronchiolitis in a Population-Based Cohort

por Lee, Henry, McLaurin, Kimmie K, Ambrose, Christopher S, Bennett, Mihoko
Publicado 2017

Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants

por Shahabi, Ahva, Peneva, Desi, Incerti, Devin, McLaurin, Kimmie, Stevens, Warren
Publicado 2017

Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations

por Bennett, Mihoko V., McLaurin, Kimmie, Ambrose, Christopher, Lee, Henry C.
Publicado 2018

Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012

por Doucette, Abigail, Jiang, Xiaohui, Fryzek, Jon, Coalson, Jenna, McLaurin, Kimmie, Ambrose, Christopher S.
Publicado 2016

A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma

por Oh, Chad K, Leigh, Richard, McLaurin, Kimmie K, Kim, Keunpyo, Hultquist, Micki, Molfino, Nestor A
Publicado 2013

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants

por Pavilack, Melissa, Clifford, Robert A., Gonzales, Tara, Kong, Amanda M., Wade, Sally, McLaurin, Kimmie K.
Publicado 2017

National Bronchiolitis Hospitalization Rates Among Preterm and Full Term Infants: 2010–2015

por Krilov, Leonard R, Fergie, Jaime, Goldstein, Mitchell, McLaurin, Kimmie K, Wade, Sally, Diakun, David, Kong, Amanda
Publicado 2017

Characteristics and health care utilization of otherwise healthy commercially and Medicaid-insured preterm and full-term infants in the US

por McLaurin, Kimmie K, Wade, Sally W, Kong, Amanda M, Diakun, David, Olajide, Ifedapo R, Germano, Jane
Publicado 2019

Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data

por Arend, Rebecca C., O’Malley, David M., Banerjee, Susana, McLaurin, Kimmie, Davidson, Richard, Long, Gráinne H.
Publicado 2021

Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer

por Simmons, Daniel, Blank, Stephanie V., ElNaggar, Adam C., Chastek, Benjamin, Bunner, Scott H., McLaurin, Kimmie
Publicado 2022

Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States

por Parikh, Rohan C., McLaurin, Kimmie K., Margulis, Andrea V., Mauskopf, Josephine, Ambrose, Christopher S., Pavilack, Melissa, Candrilli, Sean D.
Publicado 2017

Impact of Respiratory Syncytial Virus–Confirmed Hospitalizations on Caregivers of US Preterm Infants

por Pokrzywinski, Robin M., Swett, Laura L., Pannaraj, Pia S., Yi, Jumi, Pavilack, Melissa S., Kumar, Veena R., McLaurin, Kimmie K.
Publicado 2019

The 2014–2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States

por Kong, Amanda M., Krilov, Leonard R., Fergie, Jaime, Goldstein, Mitchell, Diakun, David, Wade, Sally W., Pavilack, Melissa, McLaurin, Kimmie K.
Publicado 2018

Respiratory Syncytial Virus Hospitalizations among U.S. Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophy...

por Goldstein, Mitchell, Krilov, Leonard R., Fergie, Jaime, McLaurin, Kimmie K., Wade, Sally W., Diakun, David, Lenhart, Gregory M., Bloomfield, Adam, Kong, Amanda M.
Publicado 2018

A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer

por Gao, Wei, Muston, Dominic, Monberg, Matthew, McLaurin, Kimmie, Hettle, Robert, Szamreta, Elizabeth, Swallow, Elyse, Zhang, Su, Kalemaj, Iden, Signorovitch, James, McQueen, R. Brett
Publicado 2020

The Logistics and Coordination of Respiratory Syncytial Virus Immunoprophylaxis Use Among US Pediatric Specialists

por Wong, Pierre C., Parimi, Prabhu S., Domachowske, Joseph B., Friedman, Deborah M., Marcus, Michael G., Garcia, Daniel F., La Via, William V., Syed, Iqra A., Szabo, Shelagh M., McLaurin, Kimmie K., Kumar, Veena R.
Publicado 2016

A Real-World Evidence Study of CDK4/6 Inhibitor Treatment Patterns and Outcomes in Metastatic Breast Cancer by Germline BRCA Mutation Status

por Collins, Jenna M., Nordstrom, Beth L., McLaurin, Kimmie K., Dalvi, Tapashi B., McCutcheon, Susan C., Bennett, James C., Murphy, Brian R., Singhal, Puneet K., McCrea, Charles, Shinde, Reshma, Briceno, Josefa M.
Publicado 2021

Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value

por Olchanski, Natalia, Hansen, Ryan N, Pope, Elle, D’Cruz, Brittany, Fergie, Jaime, Goldstein, Mitchell, Krilov, Leonard R, McLaurin, Kimmie K, Nabrit-Stephens, Barbara, Oster, Gerald, Schaecher, Kenneth, Shaya, Fadia T, Neumann, Peter J, Sullivan, Sean D
Publicado 2018